NCT00008424 2014-05-05
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
Children's Oncology Group
Phase 1 Completed
Clinical Trials
6 trialsNCT01141244 2014-04-10
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00006095 2014-02-21
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Children's Oncology Group
Phase 1 Completed
NCT00004919 2013-07-02
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed
NCT00016861 2013-06-26
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00024284 2013-04-05
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed